3D-QSAR illusions

Journal of Computer-Aided Molecular Design

Volumn 18, Issue 7-9, 2004, Pages 587-596

  Doweyko, Arthur M ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

CoMFA; HASL; QSAR

Indexed keywords

3D DESCRIPTOR; 3D-QSAR; ANALYTICAL TOOL; COMFA; CONSTRUCT MODELS; DESCRIPTORS; HASL; PREDICTIVITY; QSAR; TEST SETS;

DIHYDROFOLATE REDUCTASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR;

ANALYTIC METHOD; ARTICLE; BINDING SITE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG STRUCTURE; EXPERIMENTAL MODEL; INFORMATION PROCESSING; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RETROSPECTIVE STUDY; THREE DIMENSIONAL IMAGING;

EID: 20844453232     PISSN: 0920654X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10822-004-4068-0     Document Type: Article

References (60)

1. C. Hansch T. Fujita 1964 J. Am. Chem. Soc. 86 1616
2. S.M. Free Jr. J.W. Wilson 1964 J. Med. Chem. 7 395
3. Wise, M., Cramer, R.D., Smith, D. and Exman, I., In Dearden, J.C. (Ed.), Quantitative Approaches to Drug Design (Proceedings of the 4th European Symposium on Chemical Structure-Biological Activity: Quantitative Approaches), Elsevier, Amsterdam, The Netherlands, 1983, pp. 145-146.
4. Cramer III, R.D. and Wold, S.B., US Patent 5,025,388, June 18, 1991.
5. R.D. Cramer III D.E. Patterson J.D. Bunce 1988 J. Am. Chem. Soc. 110 5959
6. G. Klebe U. Abraham T. Mietzner 1994 J. Med. Chem., 37 4130
7. A.M. Doweyko 1988 J. Med. Chem., 31 1396
8. B.D. Silverman D.E. Platt 1996 J. Med. Chem., 39 2129
9. D.B. Turner P. Willet A.M. Ferguson T.W. Heritage 1997 J. Comput.-Aided Mol. Des., 11 409
10. Cruciani, G., Pastor, M. and Clementi, S., In Gundertofte, K. and Jorgensen, F.S. (Eds.), Modeling and Prediction of Activity. Kluwer, New York, 2000.
11. Thibaut, U., Folkers, G., Klebe, G., Kubinyi, H., Merz, A. and Rognan, D., In Kubinyi, H. (Ed.), 3D QSAR in Drug Design, Theory, Methods and Applications, ESCOM, Leiden, The Netherlands, 1993, pp. 711-716.
12. T. Oprea A.E. Garcia 1996 J. Comput.-Aided Mol. Des., 10 186
13. T. Oprea C.L. Waller G.R. Marshall 1994 J. Med. Chem., 37 2206
14. F.I. Carroll S.W. Mascarella M.A. Kuzemko Y. Gao P. Abraham A.H. Lewin J.W. Boja M.J. Kuhar 1994 J. Med. Chem., 37 2865
15. Klebe, G., Abraham, U. and Mietzner, T., J. Med. Chem., 37(1994) 4130.
16. Kramer, O., Bohm, M., Schlitzer, M. and Klebe, G., In Höltje, H.-D. and Sippl, W. (Eds.), Rational Approaches to Drug Design (Proceedings of the 13th European Symposium on Quantitative Structure-Activity Relationships), Prous Science, Barcelona, Spain, 2001, pp. 359-363.
17. N. Baurin E. Vangrevelinghe L. Morin-Allory J.-Y. Merour P. Renard M. Payard G. Guillaumet C. Marot 2000 J. Med. Chem., 43 1109
18. S.-X. Zhang J. Feng S.-C. Kuo A. Brossi E. Hamel A. Tropsha K.-H. Lee 2000 J. Med. Chem., 43 167
19. H. Lanig W. Utz P. Gmeiner 2001 J. Med. Chem., 44 1151
20. J.K. Buolamwini H. Assefa 2002 J. Med. Chem., 45 841
21. A.C. Nair P. Jayatilleke X. Wang S. Miertus W.J. Welsh 2002 J. Med. Chem., 45 973
22. M.A. Avery M. Alvim-Gaston C.R. Rodrigues E.J. Barreiro F.E. Cohen Y.A. Sabris J.R. Woolfrey 2002 J. Med. Chem., 45 292
23. A.K. Debnath 2002 Med. Chem., 45 41
24. D.B. Turner P. Willett A.M. Ferguson T.W. Heritage 1999 J. Comput.-Aided Mol. Des., 13 271
25. U. Norinder 1996 J. Chemometr., 10 533
26. D.D. Robinson P.J. Winn P.D. Lyne W.G. Richards 1999 J. Med. Chem., 42 573
27. M. Lobato L.l. Amat E. Besalu R. Carbo-Dorca 1997 QSAR 16 465
28. S.F. Nielsen S.B. Christensen G. Cruciani A. Kharazmi T. Liljefors 1998 J. Med. Chem., 41 4819
29. M.G. Albuquerque A.J. Hopfinger E.J. Barreiro R.B. de Alencastro 1998 J. Chem. Inf. Comput. Sci., 38 925
30. H. Kubinyi F.A. Hamprecht T. Mietzner 1998 J. Med. Chem., 41 2553
31. J. Nilsson E.J. Homan A.K. Smilde C.J. Grol H. Wikstrom 1998 J. Comput.-Aided Mol. Des., 12 81
32. J.W. McFarland 1992 J. Med. Chem., 35 2543
33. J.J. Kaminiski A.M. Doweyko 1997 J. Med. Chem., 40 427
34. A.M. Ferguson T. Heritage P. Jonathon S.E. Park L. Phillips J. Rogan P.J. Snaith 1997 J. Comput.-Aided Mol. Des., 11 143
35. D.T. Stanton 1999 J. Chem. Inf. Comput. Sci., 39 11
36. A. Tafi J. Anastassopoulou T. Theophanides M. Botta F. Corelli S. Massa M. Artico R. Costi R. Di Santo R. Ragno 1996 J. Med. Chem., 39 1227
37. J.R. Woolfrey M.A. Avery A.M. Doweyko 1998 J. Comput.-Aided Mol. Des., 12 165
38. J. Bostrom M. Bohm K. Gundertofte G. Klebe 2003 J. Chem. Inf. Comput. Sci., 43 1020
39. R.A. Pearlstein R.J. Vaz J. Kang X.-L. Chen M. Preobrazhenskaya A.E. Shchekotikhin A.M. Korolev L.N. Lysenkova O.V. Miroshnikova J. Hendrix D. Rampe 2003 Bioorg. Med. Chem. Lett., 13 1829
40. P.S. Kharkar B. Desai H. Gaveria B. Varu R. Loriya Y. Naliaparax A. Shah V.M. Kulkarni 2002 J. Med. Chem., 45 4858
41. X. Huang L. Xu X. Luo K. Fan R. Ji G. Pei K. Chen H. Jiang 2002 J. Med. Chem., 45 333
42. A.K. Chakraborti B. Gopalakrishnan M.E. Sobhia A. Malde 2003 Bioorg. Med. Chem. Lett., 13 1403
43. B.D. Silverman 2000 QSAR 19 237
44. D.B. Turner P. Willet 2000 J. Comput.-Aided Mol. Des. 14 1
45. U. Norinder 2000 J. Comput.-Aided Mol. Des., 14 545
46. A. Tafi R. Costi M. Botta R. Di Santo F. Corelli M. Federico C. Silvio A. Ciacci F. Manetti M. Artico 2002 J. Med. Chem., 45 2720
47. M. Ravi A.J. Hopfinger R.E. Hormann L. Dinan 2001 J. Chem. Inf. Comput. Sci., 41 1587
48. A. Golbraikh A. Tropsha 2002 J. Mol. Graphics 20 269
49. A. Golbraikh M. Shen Z. Xiao Y.-D. Xiao K.-H. Lee A. Tropsha 2003 J. Comput.-Aided Mol. Des. 17 241 (and ref. 21-24 within)
50. J.H. van Drie 2003 Curr. Pharm. Des., 9 1649
51. van Drie, J.H., In Bultinck, P. (Ed.), Computational Medicinal Chemistry for Drug Discovery, Marcel Dekker, New York, 2004, pp. 437-460.
52. A. Tropsha S.J. Cho 1998 Perspect. Drug Discov. Des. 12-14 56
53. RCSB (Research Collaboratory for Structural Bioinformatics), Rutgers University, NJ (www.rcsb.org/pdb).
54. Doweyko, A.M., In Holtje, H.-D. and Sippl, W. (Eds.), Rational Approaches to Drug Design (Proceedings of the 13th European Symposium on Quantitative Structure-Activity Relationships), Prous Science, Barcelona, Spain, 2001, pp. 307-315.
55. Flo(qxp), Colin McMartin, Thistlesoft, Colebrook, CT.
56. CoMFA module within Sybyl, Tripos, St. Louis, MO.
57. HASL, Hypothesis software, Long Valley, NJ.
58. S. Guccione A.M. Doweyko H. Chen G.U. Barretta F. Balzano 2000 J. Comput.-Aided Mol. Des., 14 647
59. I-Set: Twenty substituted naphthalenes (-log activity values 2.8-7.0) overlayed using a template paradigm. Activities were adjusted to optimize the CoMFA model using Gasteiger/Hückel charges.
60. SAM1-Semiempirical quantum mechanical program-implemented within Sybyl (Tripos, St. Louis, MO).